Suggested Reading
Background on Lower Urinary Tract Function
Abrams P, Cardozo L, Fall M, et al. The standardization of terminology of lower urinary tract function: Report from the Standardization Sub-Committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167-178.Diagnosis and Management of Overactive Bladder
Ellsworth PI, Wein AJ. Questions & Answers About Overactive Bladder, Second Edition: Jones and Bartlett Publishers, LLC, 2010.Irwin DE, Milsom I, Kopp Z, Abrams P, Cardozo L. Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries. BJU Int. 2006;97(1):96-100.
Kreder KJ, Dmochowski, RR. The Overactive Bladder: Evaluation and Management. London, England: Informa Healthcare; 2007.
Newman DK, Wein AJ. Managing and Treating Urinary Incontinence. 2nd ed. Baltimore, MD: Health Professions Press; 2009.
Newman DK. Assessment of the patient with an overactive bladder. J Wound Ostomy Continence Nurs. 2005;32 (3)(suppl):S5-S10.
Ouslander JG. Management of overactive bladder. N Engl J Med. 2004;350(8):786-798.
Ricci JA, Baggish JS, Hunt TL, et al. Coping strategies and health care-seeking behavior in a US national sample of adults with symptoms suggestive of overactive bladder. Clin Ther. 2001;23(8):1245-1259.
Schabert VF, Bavendam T, Goldberg EL, Trocio JN, Brubaker L. Challenges for managing overactive bladder and guidance for patient support. Am J Manag Care. 2009;15(4 suppl):S118-S122.
Shaw C, Tansey R, Jackson C, Hyde C, Allan R. Barriers to help seeking in people with urinary symptoms. Fam Pract. 2001;18(1):48-52.
Wein AJ, Rackley RR. Overactive bladder: a better understanding of pathophysiology, diagnosis and management. J Urol. 2006;175(3 Pt 2):S5-S10.
Wyman JF, Burgio KL, Newman DK. Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence. Int J Clin Pract. 2009;63(8):1177-1191.
Ziegler DK, Mosier MC, Buenaver M, Okuyemi K. How much information about adverse effects of medication do patients want from physicians? Arch Intern Med. 2001;161(5):706-713.
Treatment of Lower Urinary Tract Symptoms
Abrams P, Andersson KE, Buccafusco JJ, et al. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol. 2006;148(5):565-578.Abrams P, Drake M. Pharmacologic management of storage and emptying failure. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA (eds). Campbell-Walsh Urology, 9th Edition Review. Philadelphia, PA: Saunders Elsevier; 2007.
Andersson K-E, Appell R, Cardozo L, Nishizawa O, Vela Navarette R, Wein A. Pharmacological treatment of urinary incontinence. In: Abrams P, Cardozo L, Khoury S, Wein A (eds). 3rd International Consultation on Incontinence. Edition 2005. Monaco: Health Publications Ltd; 2005:809-854.
Chapple CR, Khullar V, Gabriel Z, Muston D, Bitoun CE, Weinstein D. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol. 2008;54(3):543-562.
Lower Urinary Tract Symptoms in Specific Populations/Overactive Bladder
Burgio KL, Locher JL, Goode PS. Combined behavioral and drug therapy for urge incontinence in older women. J Am Geriatr Soc. 2000;48(4):370-374.Chapple CR, Roehrborn CG. A shifted paradigm for the further understanding, evaluation and treatment of lower urinary tract symptoms in men: focus on the bladder. Eur Urol. 2006;49(4):651-659.
Diokno AC, Burgio K, Fultz NH, Kinchen KS, Obenchain R, Bump RC. Medical and self-care practices reported by women with urinary incontinence. Am J Manag Care. 2004;10(2 pt 1):69-78.
Sykes D, Castro R, Pons ME, et al. Characteristics of female outpatients with urinary incontinence participating in a 6-month observational study in 14 European countries. Maturitas. 2005;52 (suppl 2):S13-S23.
Assessment Tools
Amarenco G, Arnould B, Carita P, Haab F, Labat JJ, Richard F. European psychometric validation of the CONTILIFE: a Quality of Life questionnaire for urinary incontinence. Eur Urol. 2003;43(4):391-404.Black N, Griffiths J, Pope C. Development of a symptom severity index and a symptom impact index for stress incontinence in women. Neurourol Urodyn. 1996;15(6):630-640.
Cartwright R, Panayi D, Cardozo L, Khullar V. Reliability and normal ranges for the Patient’s Perception of Intensity of Urgency Scale in asymptomatic women. BJU Int. 2009 Oct 10. [Epub ahead of print.]
Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11(6):563-574.
Coyne KS, Lai J-S, Zyczynski T, Kopp Z, Avery K, Abrams P. An overactive bladder symptom and quality-of-life short form: development of the Overactive Bladder Questionnaire Short Form (OAB-q SF). Poster presented at: 34th Joint Meeting of the International Continence Society and the International UroGynecological Association; August 23-27, 2004; Paris, France. Poster 181.
Coyne KS, Zyczynski T, Margolis MK, Elinoff V, Roberts RG. Validation of an overactive bladder awareness tool for use in primary care settings. Adv Ther. 2005;22(4):381-394.
Nixon A, Colman S, Sabounjian L, et al. A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials. J Urol. 2005;174(2):604-607.
Prevalence and Burden of Bladder Symptoms
Goepel M, Hoffmann JA, Piro M, Rübben H, Michel MC. Prevalence and physician awareness of symptoms of urinary bladder dysfunction. Eur Urol. 2002;41(3):234-239.Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306-1314.
Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int. 2001;87(9):760-766.
Muller N. What Americans understand and how they are affected by bladder control problems: highlights of recent nationwide consumer research. Urol Nurs. 2005;25(2):109-115.
Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327-336.
Tyagi S, Thomas CA, Hayashi Y, Chancellor MB. The overactive bladder: epidemiology and morbidity. Urol Clin North Am. 2006;33(4):433-438, vii.